Journal for ImmunoTherapy of Cancer (Nov 2021)

263 ASD141, an innate checkpoint inhibitor, modulates tumor associated myeloid cells through CD11b and enhances current immune checkpoint blockade in preclinical model

  • Chia-Ming Chang,
  • Jason (Ping-Yen) Huang,
  • I-Fang Tsai,
  • Yen-Ta Lu

DOI
https://doi.org/10.1136/jitc-2021-SITC2021.263
Journal volume & issue
Vol. 9, no. Suppl 2

Abstract

Read online

No abstracts available.